Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Interferon alpha-2b for HCC Recurrence in HCV Cirrhosis
NCT00273247Phase 3Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Jun 1998
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon alfa-2b in hepatocellular carcinoma (HCC), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Started Jun 1998; status: completed.
02
Drugs
interferon alfa-2b
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00273247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00273247.